# Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR

> **NCT03149861** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 56 (actual)

## Conditions studied

- Neoplasm, Prostate

## Interventions

- **PROCEDURE:** PET/MR-ultrasound guided Fusion biopsy
- **PROCEDURE:** Systemic TRUS guided biopsy

## Key facts

- **NCT ID:** NCT03149861
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-08
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03149861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03149861, "Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03149861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*